Table 2.
Subspecialty | Interview respondents, n | Survey respondents, n | Total clinicians, n |
Autonomic, neuro-oncology, and neuro-ophthalmologya | 3 | 4 | 9 |
Epilepsy | 4 | 9 | 10 |
General neurology | 2 | 5 | 5 |
Headache | 4 | 3 | 5 |
Memory | 3 | 4 | 6 |
Movement disorders | 3 | 8 | 9 |
Neuroimmunology | 3 | 5 | 5 |
Neuromuscular | 4 | 5 | 8 |
Stroke | 4 | 5 | 9 |
Total | 30 (45%)b | 48 (73%)c | 66 (100%) |
aThe autonomic, neuro-oncology, and neuro-ophthalmology subspecialties had <5 clinicians and were therefore grouped to ensure anonymity.
bOf the 30 interviewees, 29 were physicians and 1 was an advanced practice provider.
cOf the 48 survey respondents, 41 were physicians and 7 were advanced practice providers.